Neuroimmunology is concerned with the relations between the central nervous and immune systems and with the mechanisms that drive those relations. The blood-brain barrier (BBB) employs mechanisms that both separate and connect these two systems. In fact, the relative immune privilege of the central nervous system (CNS) is largely attributable to the BBB's ability to prevent the unregulated exchange of immune cells and their secretions between the CNS and blood. Having separated the two systems, the BBB then participates in mechanisms that allow them to influence, communicate, and interact with one another. Likewise, the BBB itself is influenced by immune events that are occurring in the periphery and in the CNS so that these three components (the BBB, the immune system, and the CNS) form neuroimmune axes that adapt to physiological and pathological conditions. To date, four major themes have emerged by which the BBB participates in these neuroimmune axes. The first of these four, the formation of the barrier, acts to separate the immune and central nervous systems. The other three themes provide mechanisms for re-establishing communication: response of the BBB to immunomodulatory molecules (e.g., prostaglandins, cytokines, chemokines, nitric oxide) secreted by immune and CNS cells; the controlled, regulated exchange of chemokines, cytokines, and immune cells between the CNS and the blood (i.e., transport across the BBB); the secretion of immunomodulatory molecules by the BBB, often in a polarized fashion. Taken together, these mechanisms reveal the BBB to be a dynamic, interactive, and adaptable interface between the immune system and the CNS, separating them on the one hand and fostering their interactions on the other hand, adjusting to physiological changes, while being a target for disease processes. This review examines specific examples by which the BBB plays an interactive, defining role in neuroimmunology.
Introduction
The concept of a blood-brain barrier (BBB) arose from experiments done in Germany in the late half of the 19th and early part of the 20th century. This included behavioral experiments, such as those of Biedl and Kraus (1898) who found that bile acids had effects after central but not after peripheral administration, and anatomical experiments, most notably those of Paul Ehrlich who found that most dyes injected peripherally were unable to stain the brain. Ehrlich maintained that this was because brain tissue was unable to bind these dyes (Ehrlich, 1906) , but later workers found that the dyes did strain brain when injected centrally (Goldmann, 1913) . One hypothesis to explain these phenomena was that a physical barrier existed between the brain and the blood and the major contender for this site in adult mammals was the cerebrovasculature. However, both grossly and by light microscopy, the capillaries of the brain look no different than other capillary beds. It was not until the late 1960s that the ultrastructural studies of Reese and colleagues (Brightman and Reese, 1969; Reese and Karnovsky, 1967) showed that the endothelial cells of the brain differed from peripheral endothelial cells in three fundamental ways: (i) the presence of tight junctions fusing together the membranes of endothelial cells in apposition; (ii) a greatly reduced number of macropinocytotic vesicles; (iii) a greatly reduced number of canaliculi and fenestrae. Thus, both the intercellular and transcellular routes of leakage are greatly reduced at the capillary bed of the brain.
The lack of unregulated leakage at the BBB means that there is no free passage of immunoactive substances from blood to brain, including immunoglobulins. The lack of production of an http://dx.doi.org/10.1016/j.bbi.2014.08.007 0889-1591/Published by Elsevier Inc.
